Progesterone
Product Images NDC 70934-914

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 70934-914). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 914 30 Master Bottle Label Approval Rev A 10 21)

Label for Progesterone capsules 100 mg by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label states the package contains 30 capsules, prescription use only, and provides storage instructions at 20°- 25°C (68°- 77°F). Additional handling and safety advisories are included along with the NDC 70934-914-30.*

FDA Label Image

Figure 1 (Figure 1)

A line graph showing the probability of hyperplasia over time (months) on medication in patients taking conjugated estrogens alone, conjugated estrogens plus micronized progesterone (cyclical), and placebo only. The graph includes the total number of patients at each time interval (12, 24, 36 months).*

FDA Label Image

Chemical Structure (Prog Structure)

Chemical structure diagram of progesterone showing its steroid backbone with four interconnected rings and associated functional groups, including ketone moieties at specific positions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.